Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Ana M Copaescu"'
Autor:
Ana M. Copaescu, Francois Graham, Nathalie Nadon, Rémi Gagnon, Arnaud Robitaille, Mohamed Badawy, David Claveau, Anne Des Roches, Jean Paradis, Matthieu Vincent, Philippe Bégin
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 19, Iss 1, Pp 1-11 (2023)
Abstract Background High-fidelity simulations based on real-life clinical scenarios have frequently been used to improve patient care, knowledge and teamwork in the acute care setting. Still, they are seldom included in the allergy-immunology curricu
Externí odkaz:
https://doaj.org/article/100f0fcb7bce42ce96dc0bb6dc119eff
Autor:
Ibtihal AlOtaibi, Faisal Almuhizi, Shaonie Ton-Leclerc, Michael Fein, Christos Tsoukas, Lene Heise Garvey, Derek Lee, Moshe Ben-Shoshan, Ghislaine A. C. Isabwe, Ana M. Copaescu
Publikováno v:
Frontiers in Allergy, Vol 4 (2023)
Externí odkaz:
https://doaj.org/article/a49a834cf0644001992fee3a113db772
Autor:
Faisal AlMuhizi, Shaonie Ton-Leclerc, Michael Fein, Christos Tsoukas, Lene Heise Garvey, Derek Lee, Moshe Ben-Shoshan, Ghislaine A. C. Isabwe, Ana M. Copaescu
Publikováno v:
Frontiers in Allergy, Vol 3 (2022)
BackgroundCoronavirus disease 2109 (COVID-19) vaccines have recently been approved to curb the global pandemic. The risk of allergic reactions to the vaccine polyethylene glycol (PEG) component has raised significant public concern. Desensitization i
Externí odkaz:
https://doaj.org/article/628bcd59958e4de2952abe43e137e5b5
Publikováno v:
Annals of Allergy, Asthma & Immunology. 129:40-51
The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to the most rapid response and scale-up in vaccine and therapeutic development in history. We highlight the history of
Autor:
Faisal ALMuhizi, Leticia De Las Vecillas Sanchez, Lucy Gilbert, Ana M. Copaescu, Ghislaine A. C. Isabwe
Publikováno v:
Clinical Reviews in Allergy & Immunology. 62:534-547
Hypersensitivity reactions (HSRs) to chemotherapy may prevent patients from receiving the most effective therapy. This review was undertaken to identify evidence-based preventive premedication strategies that reduce the likelihood of HSR in the first
Autor:
Ana M Copaescu, Jason A Trubiano
Publikováno v:
Australian prescriber. 45(2)
Severe cutaneous adverse drug reactions include Stevens-Johnson syndrome, toxic epidermal necrolysis and acute generalised exanthematous pustulosis. These eruptions are a type of delayed hypersensitivity reaction and can be life-threatening. The asse
Publikováno v:
Immunology and allergy clinics of North America. 42(2)
Drug allergies are reported in approximately 10% of children and carry significant health and economic impacts. However, only a minority of these reported drug allergies are established on diagnostic workup. Classically, drug allergies were diagnosed
Autor:
Faisal, ALMuhizi, Michael, Fein, Sofianne, Gabrielli, Louise, Gilbert, Christos, Tsoukas, Moshe, Ben-Shoshan, Ana M, Copaescu, Ghislaine Annie Clarisse, Isabwe
Publikováno v:
Annals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology. 129(2)
Messenger RNA coronavirus disease 2019 (COVID-19) vaccines have been associated with allergic reactions. A history of anaphylaxis has been suggested as a risk factor for such reactions. Polyethylene glycol (PEG) has been proposed as a possible culpri
Publikováno v:
Current opinion in infectious diseases. 34(6)
PURPOSE OF REVIEW: The goal of this article is to provide an updated understanding and evidence-based approach where possible for antifungal hypersensitivity. This includes recognition of clinical phenotype, implications for cross-reactivity and diag
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 17, Iss 1, Pp 1-5 (2021)
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Allergic reaction to liposomal amphotericin B is rare. We report a case of cardiac arrest in a 64-year-old woman following liposomal amphotericin B infusion, requiring resuscitation. We also present the results of subsequent skin prick and intraderma